AstraZeneca and the University of Oxford on Monday reported promising efficacy data for their COVID-19 vaccine, which has less stringent storage requirements than the Pfizer and Moderna vaccines and may be distributed earlier in developing countries.
Axios Re:Cap digs into the state of vaccine and therapeutics manufacturing with Bob Nelsen, a successful biotech investor who on Monday launched Resilience, a giant new pharma production platform that he believes will prepare America for its next major health challenges.
Last week, the Centers for Disease Control and Prevention issued a warning against holiday travel. The day after, 1 million Americans got on a plane — the highest volume of travelers airports have seen since the pandemic.
Plus, how the country’s largest public university system is handling Thanksgiving.
And, the life and death implications of delaying the presidential transition.
